Ceschia, Giovanni
Gist, Katja M.
Clover-Brown, Imogen
Krallman, Kelli A.
Navarro, Ana C.
Goldstein, Stuart L.
Article History
Received: 19 June 2025
Revised: 6 August 2025
Accepted: 18 August 2025
First Online: 19 September 2025
Competing interests
: SLG reports receiving personal fees from Baxter Healthcare, BioPorto Diagnostics, Calcimedica, Fresenius, Novartis, Nuwellis, MediBeacon, Medtronic, Otsuka and SeaStar Medical. KMG reports receiving funding from the Gerber Foundation for the MINI-ROCKET study and is a consultant for Bioporto Diagnostics. She is a member of the Medical Advisory Board for SeaStar Medical and received speaker honoraria from Fresenius. None of these entities had any input into the study or manuscript, and these relationships are not relevant to the manuscript. No other disclosures were reported.